← Open Payments lookup

STEPHANIE SUMNER: Open Payments

NPI 1013550060 · LONDON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$264 in 14 payments from 8 companies in 2025. Trend: 2023 $225 · 2024 $143 · 2025 $264

Food & beverage: $264
CompanyPaymentsAmount
ABBVIE INC.4$82
Vanda Pharmaceuticals Inc.3$64
AstraZeneca Pharmaceuticals LP2$31
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$20
Collegium Pharmaceutical, Inc.1$19
Lilly USA, LLC1$17
Novo Nordisk Inc1$16
Otsuka America Pharmaceutical, Inc.1$15

Products named: VRAYLAR, FANAPT, CAPLYTA, Jornay PM, AIRSUPRA, ZEPBOUND, QULIPTA, Rybelsus.

Industry payments across KY — which companies pay providers there.